Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Reinaldo Oliva"'
Autor:
Li Hong Ying, Beatriz Tamargo Santos, Juan F. Infante Bourzac, Reinaldo Oliva Hernández, Mildrey Fariñas Medina, Dasha Fuentes Morales, V.Gustavo Sierra Gozález
Publikováno v:
Revista Habanera de Ciencias Médicas, Vol 19, Iss 1, Pp 10-29 (2020)
Introduction: Graft-versus-host disease is the most frequent complication of Hematopoietic Stem Cell Transplants and all transplants containing allogeneic immunocompetent cells; 100% of patients suffer from this complication and about 30% die for thi
Externí odkaz:
https://doaj.org/article/27fd9fddb7d64124b19ee643910783d0
Autor:
Enrique Noa, Ubel Ramirez, Tammy Boggiano, Luis Javier González, Gretchen Bergado, Vicente Verez-Bencomo, Laura Rodriguez, Yury Valdés-Balbín, Raine Garrido, Luis Ariel Espinosa, Yanet Climent, Rocmira Perez, Eduardo Ojito, Kalet León Monzón, Jean-Pierre Soubal, Sonsire Fernández, Daniel G. Rivera, Darielys Santana-Mederos, Felix Cardoso, Claudia Acosta, Lauren Quintero, Yanelys Cabrera Infante, Fabrizio Chiodo, Anamary Suarez, Sum Lai Losada, Tays Hernández, Reinaldo Oliva, Franciscary Pi, Manuel G. Ricardo, Belinda Sánchez Ramírez, Dagmar García-Rivera, Annet Valdes, Mario Landys, Cheng Fang, Yanira Méndez, Juliet Enriquez, Yassel Ramos, Humberto Gonzalez, Guang-Wu Chen, Ernesto Relova-Hernández, Tania Carmenate, Françoise Paquet, Gertrudis Rojas, Mildrey Farinas
Publikováno v:
ACS Chemical Biology
ACS Chemical Biology, American Chemical Society, 2021, 16 (7), pp.1223-1233. ⟨10.1021/acschembio.1c00272⟩
ACS Chemical Biology, American Chemical Society, 2021, 16 (7), pp.1223-1233. ⟨10.1021/acschembio.1c00272⟩
Controlling the global COVID-19 pandemic depends, among other measures, on developing preventive vaccines at an unprecedented pace. Vaccines approved for use and those in development intend to use neutralizing antibodies to block viral sites binding
Autor:
Catherine Fleitas Pérez, Juan Francisco Infante Bourzac, Gabriela Cioca, Wendy Ramirez Gonzalez, Reinaldo Oliva Hernandez, V. Gustavo Sierra Gonzalez, Yanet Marquez Napoles, Simona Bungau, Lotfi Aleya, Beatriz Tamargo Santos
Publikováno v:
Revista de Chimie (Bucharest)
Revista de Chimie (Bucharest), 2019, 70 (4)
Scopus-Elsevier
Revista de Chimie (Bucharest), 2019, 70 (4)
Scopus-Elsevier
International audience; The proteoliposomes and cochleates are used as adjuvants for vaccines since they are potent immune stimulators. However, the hyper stimulation of the immune system provoked by adjuvants can cause immunetoxicological side effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4433404910b68f19dc04f2c6e45b9f0
https://hal.archives-ouvertes.fr/hal-02129248
https://hal.archives-ouvertes.fr/hal-02129248
Publikováno v:
Revista CENIC. Ciencias Biológicas, Vol 41, Pp 1-12 (2010)
CRC3222 y CRC3241 son mutantes mshA derivados de una cepa salvaje de Vibrio cholerae O139, estos fueron obtenidos mediante una serie de modificaciones genéticas que incluyó la deleción de los genes del fago CTXfi. Dichos clones además están marc
Autor:
Rafael Fando, Celso Pérez, Beatriz Ferrán, Edith Suzarte, Talena Ledón, Karen Marrero, Joivier Vichi, Reinaldo Oliva
Publikováno v:
Microbes and infection. 14(11)
No commercially live vaccine against cholera caused by Vibrio cholerae O139 serogroup is available and it is currently needed. Virulent O139 strain CRC266 was genetically modified by firstly deleting multiple copies of the filamentous phage CTXφ, fu